Cargando…
A tool to balance benefit and harm when deciding about adjuvant therapy
Adjuvant therapy aims to prevent outgrowth of residual disease but can induce serious side effects. Weighing conflicting treatment effects and communicating this information with patients is not elementary. This study presents a scheme balancing benefit and harm of adjuvant therapy vs no adjuvant th...
Autores principales: | Knops, A M, Goossens, A, Burger, M P M, Stalpers, L J A, Ubbink, D T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661793/ https://www.ncbi.nlm.nih.gov/pubmed/19293808 http://dx.doi.org/10.1038/sj.bjc.6604962 |
Ejemplares similares
-
Decision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressed
por: Kunneman, M, et al.
Publicado: (2015) -
Observing the Observer (II): Deciding When to Decide
por: Daunizeau, Jean, et al.
Publicado: (2010) -
Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors
por: Wever, E M, et al.
Publicado: (2013) -
Deciding when to exit
por: Meserve, Joy H, et al.
Publicado: (2021) -
Deciding when to move
por: Sullivan, Lauren
Publicado: (2023)